1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > European Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape

This new five-country study from Venture Planning Group contains 700 pages, 54 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.

Complete report $11,800.  DataPack (test volumes, sales forecasts, supplier shares) $7,700.  The report is available by country, section, market segment, individual test, and can be custom-tailored to your specific information needs and budget. 


This new five-country study from Venture Planning Group contains 700 pages, 54 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. 


Report Highlights


- Business and technological trends in major markets

- Five-year test volume and sales forecasts

- Market shares of leading competitors

- Feature comparison of major analyzers

- Strategic profiles of leading market players and start-up firms developing innovative products

- Specific product and business opportunities for instrument and consumable suppliers.


Rationale


The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry.  The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.  The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.


In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.  Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.


Geographic Coverage


- France

- Germany

- Italy

- Spain

- UK


European Market Overview


- Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases

  by country and market segment.

- Five-year test volume and sales projections by country.


Market Segmentation Analysis


- Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components.


- Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays.


- A comprehensive analysis of the sequencing market by country and laboratory segment.

  

- Detailed market segmentation analysis, including review of the market dynamics, trends,

  structure, size, growth and major suppliers by country.


Product/Technology Review


- Comparison of leading infectious disease molecular diagnostic analyzers.


- Extensive review of molecular diagnostic technologies, test formats, detection methodologies,

  trends in testing automation and over target/signal amplification methods.


- Worldwide listings of companies, universities and research centers developing new molecular

   diagnostic technologies and products.


Competitive Assessments


- Extensive strategic assessments of major suppliers and emerging market entrants,

  including their sales, product portfolios, marketing tactics, collaborative arrangements and

  new technologies/products in R&D.

  

   - Abbott

   - Affymetrix

   - Agilent Technologies

   - Applied Gene Technologies

   - Arca/Nuvelo

   - Beckman Coulter/Danaher

   - Becton Dickinson

   - Biokit

   - BioMerieux

   - Bio-Rad

   - Biotest

   - Caliper

   - Cepheid

   - Decode

   - Diadexus

   - Eiken

   - Enzo

   - Exact Sciences

   - Fujirebio/Innogenetics

   - Grifols

   - Hologic/Gen-Probe

   - Illumina

   - Kreatech

   - Li-Cor Biosciences

   - Life Technologies/Thermo Fisher

   - Monogram Biosciences

   - Myriad Genetics

   - Nanogen/Elitech

   - Orchid CellMark

   - Ortho-Clinical Diagnostics

   - Proteome Sciences

   - Qiagen              

   - Roche

   - Scienion

   - Sequenom

   - Shimadzu

   - Siemens

   - Sierra Molecular

   - Takara Bio

   - Tecan Group


- Comprehensive listings of companies developing and marketing infectious disease molecular

  diagnostic products, by test and application.


Opportunities and Strategic Recommendations


- Specific new product development opportunities with potentially significant market appeal

  during the next five years.


- Design criteria for new products.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


- Business planning issues and concerns.


Contains 700 pages and 54 tables

Table Of Contents

European Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape
Table of Contents
Introduction
Global Market Trends and Emerging Technologies
A. DNA Sequencing
B. DNA And RNA Probe Technology

C. Detection Technologies

D. Instrumentation: Review of Automated and Semi-Automated Analyzers
E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip

F. Pharmacogenomics
G. Major Molecular Infectious Diseases Tests
AIDS
- Background
- Diagnostic Tests
- Vaccines and Drugs
Adenovirus/Adeno-Associated Viruses (AAV)
- Background
- Diagnostic Tests
- Vaccines and Drugs
Anthrax/Bacillus Anthracis
- Background
- Diagnostic Tests
- Vaccines and Drugs
Babesiosis
- Background
- Diagnostic Tests
- Vaccines and Drugs
BEA and Other Bartonella Diseases
- Background
- Diagnostic Tests
- Vaccines and Drugs
Chagas Disease
- Background
- Diagnostic Tests
- Vaccines and Drugs
Campylobacter
- Background
- Diagnostic Tests
- Vaccines and Drugs
Chlamydia
- Background
- Diagnostic Tests
- Vaccines and Drugs
Creutzfeldt-Jakob's Disease
- Background
- Diagnostic Tests
- Vaccines and Drugs
Cytomegalovirus
- Background
- Diagnostic Tests
- Vaccines and Drugs
Ebola Virus
- Background
- Diagnostic Tests
- Vaccines and Drugs
Echovirus
- Background
- Diagnostic Tests
- Vaccines and Drugs
Encephalitis
- Background
- Diagnostic Tests
- Vaccines and Drugs
Enteroviruses
- Background
- Diagnostic Tests
- Vaccines and Drugs
Epstein-Barr Virus
- Background
- Diagnostic Tests
- Vaccines and Drugs
Gonorrhea
- Background
- Diagnostic Tests
- Vaccines and Drugs
Hepatitis A, B, C, D, E, G
- Background
- Diagnostic Tests
- Vaccines and Drugs
Herpes Simplex Virus
- Background
- Diagnostic Tests
- Vaccines and Drugs
Legionella
- Background
- Diagnostic Tests
- Vaccines and Drugs
Lyme Disease
- Background
- Diagnostic Tests
- Vaccines and Drugs
Malaria
- Background
- Diagnostic Tests
- Vaccines and Drugs
Mycoplasma
- Background
- Diagnostic Tests
- Vaccines and Drugs
Papillomaviruses/HPV
- Background
- Diagnostic Tests
- Vaccines and Drugs
Parvovirus B19
- Background
- Diagnostic Tests
- Vaccines and Drugs
Pneumonia
- Background
- Diagnostic Tests
- Vaccines and Drugs
Polyomaviruses
- Background
- Diagnostic Tests
- Vaccines and Drugs
Salmonellosis
- Background
- Diagnostic Tests
- Vaccines and Drugs
Shigellosis
- Background
- Diagnostic Tests
- Vaccines and Drugs
Streptococci A, B
- Background
- Diagnostic Tests
- Vaccines and Drugs
Toxoplasmosis
- Background
- Diagnostic Tests
- Vaccines and Drugs
Tuberculosis
- Background
- Diagnostic Tests
- Vaccines and Drugs
West Nile Virus
- Background
- Diagnostic Tests
- Vaccines and Drugs
Yersinia
- Background
- Diagnostic Tests
- Vaccines and Drugs
H. Competing/Complementing Technologies
France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares

Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares
Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares
Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares
U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares

Major Product Development Opportunities
A. Opportunities for New Instrumentation
B. Opportunities for New Reagent Kits and Test Systems/Panels
C. Opportunities for New IT, Computers, Software and Automation
D. Opportunities for New Auxiliary Products
Design Criteria For Decentralized Testing Products
Alternative Market Penetration Strategies
Potential Market Entry Barriers And Risks


Competitive Profiles

- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca/Nuvelo
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- Biotest
- Caliper
- Cepheid
- Decode
- Diadexus
- Eiken
- Enzo
- Exact Sciences
- Fujirebio/Innogenetics
- Grifols
- Hologic/Gen-Probe
- Illumina
- Kreatech
- Li-Cor Biosciences
- Life Technologies/Thermo Fisher
- Monogram Biosciences
- Myriad Genetics
- Nanogen/Elitech
- Orchid CellMark
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Sierra Molecular
- Takara Bio
- Tecan Group
Appendixes

List of Tables
Major Companies Developing or Marketing AIDS Molecular
Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Papilloma
Virus Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic And Other Direct
Identification Tests
France, Laboratories Performing DNA Sequencing
By Market Segment
France, Molecular Diagnostics Market Potential
Laboratory Universe by Market Segment

France, Major Infectious Disease Molecular
Diagnostics Test Volume Forecast
France, Infectious Disease Screening
NAT Volume Forecast
France, Infectious Disease Screening NAT Reagent
Market Forecast by Test
France, Molecular Diagnostics Market
By Major Supplier
France, HIV/Hepatitis NAT Market Reagent Sales
By Major Supplier
Germany, Laboratories Performing
DNA Sequencing by Market Segment
Germany, Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment

Germany, Major Infectious Disease Molecular
Diagnostics Test Volume Forecast
Germany, Infectious Disease Screening
NAT Volume Forecast
Germany, Infectious Disease Screening
NAT Reagent Market Forecast by Test
Germany, Molecular Diagnostics
Market by Major Supplier
Germany, HIV/Hepatitis NAT Market Reagent
Sales by Major Supplier
Italy, Laboratories Performing
DNA Sequencing by Market Segment
Italy, Molecular Diagnostics Market Potential
Laboratory Universe by Market Segment
Italy, Major Infectious Disease Molecular
Diagnostics Test Volume Forecast
Italy, Infectious Disease Screening
NAT Volume Forecast
Italy, Infectious Disease Screening
Nat Reagent Market Forecast by Test
Italy, Molecular Diagnostics Market
By Major Supplier
Italy, HIV/Hepatitis NAT Market
By Major Supplier
Spain, Laboratories Performing
DNA Sequencing by Market Segment
Spain, Molecular Diagnostics Market, Potential
Laboratory Universe by Market Segment

Spain, Major Infectious Disease Molecular
Diagnostics Test Volume Forecast
Spain, Infectious Disease Screening
NAT Volume Forecast
Spain, Infectious Disease Screening Nat
Reagent Market Forecast by Test
Spain, Molecular Diagnostics Market
By Major Supplier

Spain, HIV/Hepatitis NAT Market Reagent
Sales by Major Supplier
U.K., Laboratories Performing
Dna Sequencing by Market Segment
U.K., Molecular Diagnostics Market Potential
Laboratory Universe by Market Segment
U.K., Major Infectious Disease Molecular
Diagnostics Test Volume Forecast
U.K., Infectious Disease Screening
NAT Volume Forecast
U.K., Infectious Disease Screening NAT Reagent
Market Forecast by Test
U.K., Molecular Diagnostics Market by Major Supplier
U.K., HIV/Hepatitis NAT Market Reagent
Sales by Major Supplier

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market and Blood Disease Statistics

  • December 2016
    8 pages
  • Therapy  

    Blood Disease  

View report >

Cardiovascular Disease Statistics in the US

  • December 2016
    171 pages
  • Cardiovascular ...  

    Therapy  

  • United States  

View report >

Public Health Industry in the UK

  • December 2016
    156 pages
  • Public Health  

    Neurological Di...  

    Hospital  

  • United Kingdom  

View report >

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.